Ensembl ID ENSG00000161057 Gene ID 5701 Accession 9548
Gene Symbol PSMC2 Alias S7;MSS1;RPT1;Nbla10058 Full Name proteasome 26S subunit, ATPase 2
Position 7 : 103328570 - 103370346 Length 41777 bases Strand Plus strand
Status Confidence Main interacting RNAsN.A.RBP type Non-canonical_RBPs
Summary The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the ATPase subunits, a member of the triple-A family of ATPases which have a chaperone-like activity. This subunit has been shown to interact with several of the basal transcription factors so, in addition to participation in proteasome functions, this subunit may participate in the regulation of transcription. This subunit may also compete with PSMC3 for binding to the HIV tat protein to regulate the interaction between the viral protein and the transcription complex. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2011]

ENSG00000161057 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000161057 PSMC2 0.42 1.35e-24 BRCA
ENSG00000161057 PSMC2 0.58 1.66e-16 COAD
ENSG00000161057 PSMC2 0.71 3.33e-20 LUSC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000161057 PSMC2 cancer 10363654
ENSG00000161057 PSMC2 tumour 15477867
ENSG00000161057 PSMC2 tumor 16317774
ENSG00000161057 PSMC2 tumor 23980094
ENSG00000161057 PSMC2 tumors 27888613
ENSG00000161057 PSMC2 Cancer 31598166
ENSG00000161057 PSMC2 Colorectal Cancer 31715603
ENSG00000161057 PSMC2 cancer 9228288
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000161057 PSMC2 MESO 0.0068 high
ENSG00000161057 PSMC2 SARC 0.038 low
ENSG00000161057 PSMC2 THCA 0.0079 low
ENSG00000161057 PSMC2 LUSC 0.026 low
ENSG00000161057 PSMC2 HNSC 0.032 high
ENSG00000161057 PSMC2 THYM 0.046 high
ENSG00000161057 PSMC2 UCS 0.035 high
ENSG00000161057 PSMC2 OV 0.012 low
ENSG00000161057 PSMC2 DLBC 0.0081 low
ENSG00000161057 PSMC2 KIRC 0.006 high
ENSG00000161057 PSMC2 BLCA 0.038 high
ENSG00000161057 PSMC2 LAML 0.0059 high
ENSG00000161057 PSMC2 GBM 0.00058 high
ENSG00000161057 PSMC2 SKCM 0.0043 low
ENSG00000161057 PSMC2 LIHC 0.0029 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000161057 PSMC2 LGG Amp 2.693131 0.072329 0.663392 0.325536
ENSG00000161057 PSMC2 KIRP Amp 1.201103 0.067832 0.924684 0.604167
ENSG00000161057 PSMC2 ESCA Amp 4.451562 0.453255 0.698703 0.538043
ENSG00000161057 PSMC2 HNSC Amp 4.784556 0.199774 0.576961 0.312261
ENSG00000161057 PSMC2 STAD Amp 2.459877 0.181331 0.531804 0.412698